Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease P Holvoet, J Vanhaecke, S Janssens, F Van de Werf, D Collen Circulation 98 (15), 1487-1494, 1998 | 910 | 1998 |
Obesity, regional body fat distribution, and the metabolic syndrome in older men and women BH Goodpaster, S Krishnaswami, TB Harris, A Katsiaras, SB Kritchevsky, ... Archives of internal medicine 165 (7), 777-783, 2005 | 892 | 2005 |
Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease P Holvoet, A Mertens, P Verhamme, K Bogaerts, G Beyens, R Verhaeghe, ... Arteriosclerosis, thrombosis, and vascular biology 21 (5), 844-848, 2001 | 698 | 2001 |
Oxidized LDL and HDL: antagonists in atherothrombosis ANN Mertens, P Holvoet The FASEB journal 15 (12), 2073-2084, 2001 | 650 | 2001 |
Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis I Juhan-Vague, J Valadier, MC Alessi, MF Aillaud, J Ansaldi, C Philip-Joet, ... Thrombosis and haemostasis 57 (01), 067-072, 1987 | 542 | 1987 |
Biomechanical factors in atherosclerosis: mechanisms and clinical implications BR Kwak, M Bäck, ML Bochaton-Piallat, G Caligiuri, MJAP Daemen, ... European heart journal 35 (43), 3013-3020, 2014 | 509 | 2014 |
The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort P Holvoet, SB Kritchevsky, RP Tracy, A Mertens, SM Rubin, J Butler, ... Diabetes 53 (4), 1068-1073, 2004 | 500 | 2004 |
Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome P Holvoet, DH Lee, M Steffes, M Gross, DR Jacobs Jama 299 (19), 2287-2293, 2008 | 405 | 2008 |
Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review R Navickas, D Gal, A Laucevičius, A Taparauskaitė, M Zdanytė, P Holvoet Cardiovascular research 111 (4), 322-337, 2016 | 365 | 2016 |
MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease M Hulsmans, P Holvoet Cardiovascular research 100 (1), 7-18, 2013 | 358 | 2013 |
Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. P Holvoet, G Perez, Z Zhao, E Brouwers, H Bernar, D Collen The Journal of clinical investigation 95 (6), 2611-2619, 1995 | 340 | 1995 |
The vicious circle between oxidative stress and inflammation in atherosclerosis M Hulsmans, P Holvoet Journal of cellular and molecular medicine 14 (1‐2), 70-78, 2010 | 321 | 2010 |
Oxidized lipoproteins in atherosclerosis and thrombosis P Holvoet, D Collen The FASEB journal 8 (15), 1279-1284, 1994 | 309 | 1994 |
Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA P Holvoet, H Cleemput, D Collen Thrombosis and haemostasis 54 (07), 684-687, 1985 | 304 | 1985 |
Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease P Holvoet Verh K Acad Geneeskd Belg 70 (3), 193-219, 2008 | 283 | 2008 |
Oxidative stress and insulin resistance: the coronary artery risk development in young adults study K Park, M Gross, DH Lee, P Holvoet, JH Himes, JM Shikany, ... Diabetes care 32 (7), 1302-1307, 2009 | 278 | 2009 |
MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis M Hulsmans, DD Keyzer, P Holvoet The FASEB Journal 25 (8), 2515-2527, 2011 | 269 | 2011 |
The importance of catch‐up growth after early malnutrition for the programming of obesity in male rat F Bieswal, MT Ahn, B Reusens, P Holvoet, M Raes, WD Rees, C Remacle Obesity 14 (8), 1330-1343, 2006 | 265 | 2006 |
Metabolic syndrome and the risk of cardiovascular disease in older adults J Butler, N Rodondi, Y Zhu, K Figaro, S Fazio, DE Vaughan, S Satterfield, ... Journal of the American College of Cardiology 47 (8), 1595-1602, 2006 | 257 | 2006 |
Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in … R Quarck, B De Geest, D Stengel, A Mertens, M Lox, G Theilmeier, ... Circulation 103 (20), 2495-2500, 2001 | 254 | 2001 |